Literature DB >> 24883430

Bioactive oligosaccharide natural products.

Emilianne K McCranie1, Brian O Bachmann.   

Abstract

Covering up to December 2013. Oligosaccharide natural products target a wide spectrum of biological processes including disruption of cell wall biosynthesis, interference of bacterial translation, and inhibition of human α-amylase. Correspondingly, oligosaccharides possess the potential for development as treatments of such diverse diseases as bacterial infections and type II diabetes. Despite their potent and selective activities and potential clinical relevance, isolated bioactive secondary metabolic oligosaccharides are less prevalent than other classes of natural products and their biosynthesis has received comparatively less attention. This review highlights the unique modes of action and biosynthesis of four classes of bioactive oligosaccharides: the orthosomycins, moenomycins, saccharomicins, and acarviostatins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24883430      PMCID: PMC5267508          DOI: 10.1039/c3np70128j

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  101 in total

1.  Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.

Authors:  U S Eggert; N Ruiz; B V Falcone; A A Branstrom; R C Goldman; T J Silhavy; D Kahne
Journal:  Science       Date:  2001-08-23       Impact factor: 47.728

2.  Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals.

Authors:  P Butaye; L A Devriese; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Biosynthesis of the orthosomycin antibiotic avilamycin A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics.

Authors:  G Weitnauer; A Mühlenweg; A Trefzer; D Hoffmeister; R D Süssmuth; G Jung; K Welzel; A Vente; U Girreser; A Bechthold
Journal:  Chem Biol       Date:  2001-06

4.  Moenomycin, an inhibitor of cell wall synthesis.

Authors:  G Huber; G Nesemann
Journal:  Biochem Biophys Res Commun       Date:  1968-01-11       Impact factor: 3.575

5.  Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. II: Structure elucidation.

Authors:  Ryuji Uchida; Masato Iwatsuki; Yong-Pil Kim; Satoshi Omura; Hiroshi Tomoda
Journal:  J Antibiot (Tokyo)       Date:  2010-03-05       Impact factor: 2.649

6.  Pholipomycin, a new member of phosphoglycolipid antibiotics. I. Taxonomy of producing organism and fermentation and isolation of pholipomycin.

Authors:  M Arai; A Torikata; R Enokita; H Fukatsu; R Nakayama; K Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

7.  The active conformation of avilamycin A is conferred by AviX12, a radical AdoMet enzyme.

Authors:  Raija Boll; Carsten Hofmann; Björn Heitmann; Gerd Hauser; Steffen Glaser; Thorsten Koslowski; Thorsten Friedrich; Andreas Bechthold
Journal:  J Biol Chem       Date:  2006-03-14       Impact factor: 5.157

8.  Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors.

Authors:  Christian M Gampe; Hirokazu Tsukamoto; Emma H Doud; Suzanne Walker; Daniel Kahne
Journal:  J Am Chem Soc       Date:  2013-03-04       Impact factor: 15.419

Review 9.  Biosynthesis of unusual aminocyclitol-containing natural products.

Authors:  Taifo Mahmud; Patricia M Flatt; Xiumei Wu
Journal:  J Nat Prod       Date:  2007-07-28       Impact factor: 4.050

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  25 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 2.  Oxidative Cyclization in Natural Product Biosynthesis.

Authors:  Man-Cheng Tang; Yi Zou; Kenji Watanabe; Christopher T Walsh; Yi Tang
Journal:  Chem Rev       Date:  2016-12-12       Impact factor: 60.622

Review 3.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

4.  An Improved Approach to the Direct Construction of 2-Deoxy-β-Linked Sugars: Applications to Oligosaccharide Synthesis.

Authors:  Dina Lloyd; Clay S Bennett
Journal:  Chemistry       Date:  2018-05-02       Impact factor: 5.236

Review 5.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

6.  Context-based sensing of orthosomycin antibiotics by the translating ribosome.

Authors:  Kyle Mangano; James Marks; Dorota Klepacki; Chayan Kumar Saha; Gemma C Atkinson; Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Nat Chem Biol       Date:  2022-09-22       Impact factor: 16.174

7.  An atypical orphan carbohydrate-NRPS genomic island encodes a novel lytic transglycosylase.

Authors:  Xun Guo; Jason M Crawford
Journal:  Chem Biol       Date:  2014-09-11

8.  Rapid de Novo Preparation of 2,6-Dideoxy Sugar Libraries through Gold-Catalyzed Homopropargyl Orthoester Cyclization.

Authors:  Subbarao Yalamanchili; William Miller; Xizhao Chen; Clay S Bennett
Journal:  Org Lett       Date:  2019-11-22       Impact factor: 6.005

Review 9.  Microbial Oligosaccharides with Biomedical Applications.

Authors:  Jian-Lin Xu; Zhi-Feng Liu; Xiao-Wei Zhang; Hai-Li Liu; Yong Wang
Journal:  Mar Drugs       Date:  2021-06-21       Impact factor: 5.118

10.  An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia.

Authors:  Yasuhiko Matsumoto; Masaki Ishii; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.